132 related articles for article (PubMed ID: 31790201)
1. Small-Molecule Modulators of the ATPase VCP/p97 Affect Specific p97 Cellular Functions.
Figuerola-Conchas A; Saarbach J; Daguer JP; Cieren A; Barluenga S; Winssinger N; Gotta M
ACS Chem Biol; 2020 Jan; 15(1):243-253. PubMed ID: 31790201
[TBL] [Abstract][Full Text] [Related]
2. Novel p97/VCP inhibitor induces endoplasmic reticulum stress and apoptosis in both bortezomib-sensitive and -resistant multiple myeloma cells.
Nishimura N; Radwan MO; Amano M; Endo S; Fujii E; Hayashi H; Ueno S; Ueno N; Tatetsu H; Hata H; Okamoto Y; Otsuka M; Mitsuya H; Matsuoka M; Okuno Y
Cancer Sci; 2019 Oct; 110(10):3275-3287. PubMed ID: 31368616
[TBL] [Abstract][Full Text] [Related]
3. Specific inhibition of p97/VCP ATPase and kinetic analysis demonstrate interaction between D1 and D2 ATPase domains.
Chou TF; Bulfer SL; Weihl CC; Li K; Lis LG; Walters MA; Schoenen FJ; Lin HJ; Deshaies RJ; Arkin MR
J Mol Biol; 2014 Jul; 426(15):2886-99. PubMed ID: 24878061
[TBL] [Abstract][Full Text] [Related]
4. p97 Composition Changes Caused by Allosteric Inhibition Are Suppressed by an On-Target Mechanism that Increases the Enzyme's ATPase Activity.
Her NG; Toth JI; Ma CT; Wei Y; Motamedchaboki K; Sergienko E; Petroski MD
Cell Chem Biol; 2016 Apr; 23(4):517-28. PubMed ID: 27105284
[TBL] [Abstract][Full Text] [Related]
5. A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 and NMS-873 in colorectal cancer cells.
Zhang G; Li S; Wang F; Jones AC; Goldberg AFG; Lin B; Virgil S; Stoltz BM; Deshaies RJ; Chou TF
Eur J Med Chem; 2021 Mar; 213():113148. PubMed ID: 33476933
[TBL] [Abstract][Full Text] [Related]
6. ATP binding to p97/VCP D1 domain regulates selective recruitment of adaptors to its proximal N-domain.
Chia WS; Chia DX; Rao F; Bar Nun S; Geifman Shochat S
PLoS One; 2012; 7(12):e50490. PubMed ID: 23226521
[TBL] [Abstract][Full Text] [Related]
7. Structural and mechanistic insights into the arginine/lysine-rich peptide motifs that interact with P97/VCP.
Liu S; Fu QS; Zhao J; Hu HY
Biochim Biophys Acta; 2013 Dec; 1834(12):2672-8. PubMed ID: 24100225
[TBL] [Abstract][Full Text] [Related]
8. Evaluating p97 inhibitor analogues for their domain selectivity and potency against the p97-p47 complex.
Fang CJ; Gui L; Zhang X; Moen DR; Li K; Frankowski KJ; Lin HJ; Schoenen FJ; Chou TF
ChemMedChem; 2015 Jan; 10(1):52-6. PubMed ID: 25377500
[TBL] [Abstract][Full Text] [Related]
9. A Fragment-Based Ligand Screen Against Part of a Large Protein Machine: The ND1 Domains of the AAA+ ATPase p97/VCP.
Chimenti MS; Bulfer SL; Neitz RJ; Renslo AR; Jacobson MP; James TL; Arkin MR; Kelly MJ
J Biomol Screen; 2015 Jul; 20(6):788-800. PubMed ID: 25690569
[TBL] [Abstract][Full Text] [Related]
10. Mutant p97 exhibits species-specific changes of its ATPase activity and compromises the UBXD9-mediated monomerisation of p97 hexamers.
Rijal R; Arhzaouy K; Strucksberg KH; Cross M; Hofmann A; Schröder R; Clemen CS; Eichinger L
Eur J Cell Biol; 2016; 95(6-7):195-207. PubMed ID: 27132113
[TBL] [Abstract][Full Text] [Related]
11. A unique IBMPFD-related P97/VCP mutation with differential binding pattern and subcellular localization.
Erzurumlu Y; Kose FA; Gozen O; Gozuacik D; Toth EA; Ballar P
Int J Biochem Cell Biol; 2013 Apr; 45(4):773-82. PubMed ID: 23333620
[TBL] [Abstract][Full Text] [Related]
12. Central pore residues mediate the p97/VCP activity required for ERAD.
DeLaBarre B; Christianson JC; Kopito RR; Brunger AT
Mol Cell; 2006 May; 22(4):451-62. PubMed ID: 16713576
[TBL] [Abstract][Full Text] [Related]
13. Common Mode of Remodeling AAA ATPases p97/CDC48 by Their Disassembling Cofactors ASPL/PUX1.
Banchenko S; Arumughan A; Petrović S; Schwefel D; Wanker EE; Roske Y; Heinemann U
Structure; 2019 Dec; 27(12):1830-1841.e3. PubMed ID: 31648844
[TBL] [Abstract][Full Text] [Related]
14. Ubxd1 is a novel co-factor of the human p97 ATPase.
Madsen L; Andersen KM; Prag S; Moos T; Semple CA; Seeger M; Hartmann-Petersen R
Int J Biochem Cell Biol; 2008; 40(12):2927-42. PubMed ID: 18656546
[TBL] [Abstract][Full Text] [Related]
15. p97 Disease Mutations Modulate Nucleotide-Induced Conformation to Alter Protein-Protein Interactions.
Bulfer SL; Chou TF; Arkin MR
ACS Chem Biol; 2016 Aug; 11(8):2112-6. PubMed ID: 27267671
[TBL] [Abstract][Full Text] [Related]
16. Regulation of ER-associated degradation via p97/VCP-interacting motif.
Ballar P; Fang S
Biochem Soc Trans; 2008 Oct; 36(Pt 5):818-22. PubMed ID: 18793143
[TBL] [Abstract][Full Text] [Related]
17. Structural basis of the interaction between the AAA ATPase p97/VCP and its adaptor protein p47.
Dreveny I; Kondo H; Uchiyama K; Shaw A; Zhang X; Freemont PS
EMBO J; 2004 Mar; 23(5):1030-9. PubMed ID: 14988733
[TBL] [Abstract][Full Text] [Related]
18. p97/valosin-containing protein (VCP) is highly modulated by phosphorylation and acetylation.
Mori-Konya C; Kato N; Maeda R; Yasuda K; Higashimae N; Noguchi M; Koike M; Kimura Y; Ohizumi H; Hori S; Kakizuka A
Genes Cells; 2009 Apr; 14(4):483-97. PubMed ID: 19335618
[TBL] [Abstract][Full Text] [Related]
19. Uncoupling of p97 ATPase activity has a dominant negative effect on protein extraction.
Rycenga HB; Wolfe KB; Yeh ES; Long DT
Sci Rep; 2019 Jul; 9(1):10329. PubMed ID: 31316150
[TBL] [Abstract][Full Text] [Related]
20. A Dynamic molecular basis for malfunction in disease mutants of p97/VCP.
Schuetz AK; Kay LE
Elife; 2016 Nov; 5():. PubMed ID: 27828775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
